Contrary to claims that the youth benefit more from flu vaccines, a t10-year study has found that annual influenza vaccinations can also reduce the hospitalisation rate and delay mortality among the elderly.
"This study evidences protection for an elderly population for whom vaccine efficacy has been questioned," said study co-author Stefan Gravenstein, adjunct professor of medicine and health services, policy and practice at Brown University in Rhode Island, US.
"Annual vaccination is the only way to maximise the benefit of vaccine, no matter what the age," Gravenstein noted.
The researchers found that between 2000 and 2009, the better matched the vaccine was for the influenza strain going around, the fewer residents in US nursing home died or were hospitalised.
For the study, the researchers analysed records of millions of nursing home residents.
Year-to-year the ability of the vaccine to fight the flu can vary widely. Sometimes vaccine makers produce a great match that is highly protective. In other years the prevailing flu strain does not match the vaccine well.
The researchers took advantage of this natural variation over the decade 2000-09 to see whether nursing home residents were better off when the match was good compared to when the match was bad.
If vaccines do not help the elderly, as some critics suggest, then nursing home residents should not fare any better when the vaccine is a good match than when it is a bad match.
The results showed that vaccinations help keep some nursing home residents alive and out of the hospital.
The study was published in the Journal of the American Geriatrics Society.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
